Docetaxel and doxorubicin compared with doxorubicin and cyclophosphamide as first-line chemotherapy for metastatic breast cancer: results of a randomized, multicenter, phase III trial. (Q44362096)
Jump to navigation
Jump to search
scientific article published in March 2003
Language | Label | Description | Also known as |
---|---|---|---|
English | Docetaxel and doxorubicin compared with doxorubicin and cyclophosphamide as first-line chemotherapy for metastatic breast cancer: results of a randomized, multicenter, phase III trial. |
scientific article published in March 2003 |
Statements
Docetaxel and doxorubicin compared with doxorubicin and cyclophosphamide as first-line chemotherapy for metastatic breast cancer: results of a randomized, multicenter, phase III trial (English)
Jean-Marc Nabholtz
Daniel Campos
Janos Szanto
Stephen Chan
Jerzy Zaluski
Tamas Pinter
Daniel Vorobiof
Robert Leonard
Ian Kennedy
Nacer Azli
Michael Murawsky
Alessandro Riva
Pierre Pouillart
TAX 306 Study Group